<DOC>
	<DOC>NCT00819884</DOC>
	<brief_summary>The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing</brief_summary>
	<brief_title>To Evaluate 24-hr Glucose After OD vs BD AZD1656</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>type II diabetes patients, female with non childbearing potential Type 2 Diabetes Mellitus (T2DM) diagnosis confirmed by Cpeptide &gt;0.3nmol/L and no Glutamic acid decarboxylase (GAD) antibodies at enrolment (screening) Treatment with metformin as single therapy for T2DM for at least 30 days prior to enrolment and the metformin dose must have been unchanged during this period History of ischemic heart disease, symptomatic heart failure, stroke, transitory ischemic attack or symptomatic peripheral vascular disease Any clinically significant abnormality identified on physical examination, laboratory test or ECG, which in the judgement of investigator would compromise the subject's safety or successful participation in the clinical study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Type II Diabetes</keyword>
	<keyword>24 hour glucose profile</keyword>
</DOC>